Multicenter Evaluation of Patients Using LATITUDE Monitoring System

Launched by UNIVERSITY HOSPITAL OF FERRARA · Mar 7, 2024

Keywords

ClinConnect Summary

The Multitude trial is studying how well the LATITUDE monitoring system works for patients who have devices to help manage heart conditions, like heart failure or arrhythmias. This system allows doctors to keep track of important health information from these devices remotely, meaning they can monitor patients' heart health without needing them to come into the office as often. By gathering data from many patients across Europe, researchers hope to better understand the effectiveness of these devices and improve care for individuals with heart problems.

To participate in the trial, you should be scheduled to receive a LATITUDE-monitored device or have already received one. It's important that you are willing to share your health information for research purposes. However, if you won't be followed by the enrolling center for at least a year after getting the device, or if your device isn't approved for commercial use, you may not be eligible. Participants can expect to contribute to valuable research that could enhance heart care for many people in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subject is willing and capable of providing informed consent to collect/store/process personal health information by the sponsor or such consent is provided by a legally designated representative, if required by local law or regulation.
• * Subject is:
• • 1. prospectively scheduled for receiving a device monitored through the LATITUDE monitoring system
• • 2. retrospectively enrolled after having received a device monitored through the LATITUDE monitoring system
• Exclusion Criteria:
• • Subject foreseen not to be followed at the enrolling center for at least 1 year after having received the device.
• • Subject is receiving a device that is not approved for commercial use at the time of procedure.